Analyst Ratings for Better Therapeutics (BTTX)

BTTX Rating Summary

BTTX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BTTX
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $16.00 (+846.7%) * Over Last 12-Mos
Rating Score: 10 / 10
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/28/2021 LifeSci Capital Rahul Rakhit New Coverage Outperform
(N/A)
15.00
(N/A)
5.39
(1.69)
-68.65% Details
11/24/2021 Chardan Capital Markets Keay Naka New Coverage Buy
(N/A)
17.00
(N/A)
6.41
(1.69)
-73.63% Details
Like BTTX Ratings? Also take a look at EXEL, MYOV, CERN, CI

BTTX Ratings News